Absci Reports Third Quarter 2022 Financial Results

Absci Reports Third Quarter 2022 Financial Results

Milestone achievement and progress continues in previously announced Merck collaboration Further strengthened executive leadership and Board of Directors VANCOUVER, Wash. and NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a...
Absci Welcomes Meta Senior Executive to Board of Directors

Absci Welcomes Meta Senior Executive to Board of Directors

Technology veteran Dan Rabinovitsj provides expertise in collaborating with technology partners to catalyze innovation as Absci accelerates generative AI drug creation VANCOUVER, Wash. and NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq:...